Poster: Enhancing Cardiometabolic Disease Research through AccessCMD
A Novel Approach to Patient Recruitment and Data Collection
The burden of cardiometabolic diseases (CMD) such as diabetes, heart disease, and stroke, along with associated risk factors like obesity, hypertension, and hyperlipidemia, represents a global health crisis that significantly impacts life expectancy, quality of life, and healthcare costs.To address this challenge, the AccessCMD project aims to create a comprehensive registry with recall capacity for CMD and multimorbidity.This initiative leverages electronic health records (EHR) to identify potential participants, enhancing our understanding of CMD through robust data collection and participant engagement strategies.

Related articles
Continue reading

Company News
Partners
October 30, 2025
Partnering with WellSky to expand the reach of real-world data
Read more

Company News
Product
May 1, 2025
uMed Launches SnapACCESS: A Groundbreaking Solution for Agile and Compliant Patient Data Insights in Diabetes and Obesity Research
Read more

Company News
November 21, 2024
uMed’s AccessPD Interactive Parkinson’s Registry Surpasses 1000 Participants
Read more
Book a complimentary demonstration.
For a clear picture of how uMed could work for you, book a free session with our team.
hello@umed.io
hello@umed.io

